Spironolactone mitigates, but does not reverse, the progression of renal fibrosis in a transgenic hypertensive ratCatherine Leader(University of Otago), Robert Walker(University of Otago)Physiological ReportsMay 1, 202010.14814/phy2.14448Cited by 12SaveCiteExport RISWatch citationsRelated PapersAnthelmintic drugs and nematicides: studies in Caenorhabditis elegans|WormBook|2014|170Renal Fibrosis mRNA Classifier: Validation in Experimental Lithium-Induced Interstitial Fibrosis in the Rat Kidney|PLoS ONE|2016|9